Adoptive Cellular Immunotherapy Market Report

China Adoptive Cellular Immunotherapy Market Professional Research Report 2022-2027, Segmented by Players, Types, End-Users in Major Regions

  • POSTDATE：Aug 20, 2022
  • PAGES：181
  • REPORT CODE：GMM1042308
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report offers an overview of the market trends, drivers, and barriers with respect to the China Adoptive Cellular Immunotherapy market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Adoptive Cellular Immunotherapy market. Detailed analysis of key players, along with key growth strategies adopted by Adoptive Cellular Immunotherapy industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd

    • Celyad SA

    • Fosun Pharmaceutical AG

    • Autolus Therapeutics Plc

    • Takara Bio Inc

    • Celgene Corp

    • Gilead Sciences Inc

    • Amgen Inc

    • Nkarta Inc

    • Cell Medica Ltd

    • Beijing Immunochina Medical Science & Technology Co Ltd

    • Hebei Senlang Biotechnology Inc Ltd

    • Kite Pharma Inc

    • Bristol-Myers Squibb Co

    • Nanjing Legend Biotech Co Ltd

    • Novartis AG

    • Juno Therapeutics Inc

    • Guangzhou Anjie Biomedical Technology Co Ltd

    • NantKwest Inc

    • bluebird bio Inc

    • HRAIN Biotechnology Co Ltd

    • Bellicum Pharmaceuticals Inc

    • Ono Pharmaceutical Co Ltd

    • Daiichi Sankyo Co Ltd

    • Sorrento Therapeutics Inc

    • Celularity Inc

    • Hangzhou Converd Co Ltd

    • Cellular Biomedicine Group Inc

    • CARsgen Therapeutics Ltd

    By Type:

    • TIL

    • LAK

    • CAR-T

    • TCR-T

    • CIK

    • NK

    • DC

    • Other

    By End-User:

    • Hospital

    • Cancer Hospital

    • Centers for Disease Control and Prevention

    • Rehabilitation Center

    • Other

    By Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Adoptive Cellular Immunotherapy Market

    • 1.3 Market Segment by Type

    • 1.3.1 China Adoptive Cellular Immunotherapy Market Size and Growth Rate of TIL from 2016 to 2027

    • 1.3.2 China Adoptive Cellular Immunotherapy Market Size and Growth Rate of LAK from 2016 to 2027

    • 1.3.3 China Adoptive Cellular Immunotherapy Market Size and Growth Rate of CAR-T from 2016 to 2027

    • 1.3.4 China Adoptive Cellular Immunotherapy Market Size and Growth Rate of TCR-T from 2016 to 2027

    • 1.3.5 China Adoptive Cellular Immunotherapy Market Size and Growth Rate of CIK from 2016 to 2027

    • 1.3.6 China Adoptive Cellular Immunotherapy Market Size and Growth Rate of NK from 2016 to 2027

    • 1.3.7 China Adoptive Cellular Immunotherapy Market Size and Growth Rate of DC from 2016 to 2027

    • 1.3.8 China Adoptive Cellular Immunotherapy Market Size and Growth Rate of Other from 2016 to 2027

    • 1.4 Market Segment by Application

    • 1.4.1 China Adoptive Cellular Immunotherapy Market Size and Growth Rate of Hospital from 2016 to 2027

    • 1.4.2 China Adoptive Cellular Immunotherapy Market Size and Growth Rate of Cancer Hospital from 2016 to 2027

    • 1.4.3 China Adoptive Cellular Immunotherapy Market Size and Growth Rate of Centers for Disease Control and Prevention from 2016 to 2027

    • 1.4.4 China Adoptive Cellular Immunotherapy Market Size and Growth Rate of Rehabilitation Center from 2016 to 2027

    • 1.4.5 China Adoptive Cellular Immunotherapy Market Size and Growth Rate of Other from 2016 to 2027

    • 1.5 Market Segment by Regions

      • 1.5.1 North China Adoptive Cellular Immunotherapy Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.2 Central China Adoptive Cellular Immunotherapy Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.3 South China Adoptive Cellular Immunotherapy Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.4 East China Adoptive Cellular Immunotherapy Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.5 Northeast China Adoptive Cellular Immunotherapy Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.6 Southwest China Adoptive Cellular Immunotherapy Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.7 Northwest China Adoptive Cellular Immunotherapy Consumption Market Size and Growth Rate from 2016 to 2027

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    • 2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry

    3 Segmentation of Adoptive Cellular Immunotherapy Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Adoptive Cellular Immunotherapy by Major Types

    • 3.4.1 Market Size and Growth Rate of TIL

    • 3.4.2 Market Size and Growth Rate of LAK

    • 3.4.3 Market Size and Growth Rate of CAR-T

    • 3.4.4 Market Size and Growth Rate of TCR-T

    • 3.4.5 Market Size and Growth Rate of CIK

    • 3.4.6 Market Size and Growth Rate of NK

    • 3.4.7 Market Size and Growth Rate of DC

    • 3.4.8 Market Size and Growth Rate of Other

    4 Segmentation of Adoptive Cellular Immunotherapy Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Adoptive Cellular Immunotherapy by Major End-Users

    • 4.4.1 Market Size and Growth Rate of Adoptive Cellular Immunotherapy in Hospital

    • 4.4.2 Market Size and Growth Rate of Adoptive Cellular Immunotherapy in Cancer Hospital

    • 4.4.3 Market Size and Growth Rate of Adoptive Cellular Immunotherapy in Centers for Disease Control and Prevention

    • 4.4.4 Market Size and Growth Rate of Adoptive Cellular Immunotherapy in Rehabilitation Center

    • 4.4.5 Market Size and Growth Rate of Adoptive Cellular Immunotherapy in Other

    5 Market Analysis by Regions

    • 5.1 China Adoptive Cellular Immunotherapy Production Analysis by Regions

    • 5.2 China Adoptive Cellular Immunotherapy Consumption Analysis by Regions

    • 5.3 Coronavirus (COVID-19) Impact on China Economy

    6 North China Adoptive Cellular Immunotherapy Landscape Analysis

    • 6.1 North China Adoptive Cellular Immunotherapy Landscape Analysis by Major Types

    • 6.2 North China Adoptive Cellular Immunotherapy Landscape Analysis by Major End-Users

    7 Central China Adoptive Cellular Immunotherapy Landscape Analysis

    • 7.1 Central China Adoptive Cellular Immunotherapy Landscape Analysis by Major Types

    • 7.2 Central China Adoptive Cellular Immunotherapy Landscape Analysis by Major End-Users

    8 South China Adoptive Cellular Immunotherapy Landscape Analysis

    • 8.1 South China Adoptive Cellular Immunotherapy Landscape Analysis by Major Types

    • 8.2 South China Adoptive Cellular Immunotherapy Landscape Analysis by Major End-Users

    9 East China Adoptive Cellular Immunotherapy Landscape Analysis

    • 9.1 East China Adoptive Cellular Immunotherapy Landscape Analysis by Major Types

    • 9.2 East China Adoptive Cellular Immunotherapy Landscape Analysis by Major End-Users

    10 Northeast China Adoptive Cellular Immunotherapy Landscape Analysis

    • 10.1 Northeast China Adoptive Cellular Immunotherapy Landscape Analysis by Major Types

    • 10.2 Northeast China Adoptive Cellular Immunotherapy Landscape Analysis by Major End-Users

    11 Southwest China Adoptive Cellular Immunotherapy Landscape Analysis

    • 11.1 Southwest China Adoptive Cellular Immunotherapy Landscape Analysis by Major Types

    • 11.2 Southwest China Adoptive Cellular Immunotherapy Landscape Analysis by Major End-Users

    12 Northwest China Adoptive Cellular Immunotherapy Landscape Analysis

    • 12.1 Northwest China Adoptive Cellular Immunotherapy Landscape Analysis by Major Types

    • 12.2 Northwest China Adoptive Cellular Immunotherapy Landscape Analysis by Major End-Users

    13 Major Players Profiles

    • 13.1 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd

      • 13.1.1 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Company Profile and Recent Development

      • 13.1.2 Market Performance

      • 13.1.3 Product and Service Introduction

    • 13.2 Celyad SA

      • 13.2.1 Celyad SA Company Profile and Recent Development

      • 13.2.2 Market Performance

      • 13.2.3 Product and Service Introduction

    • 13.3 Fosun Pharmaceutical AG

      • 13.3.1 Fosun Pharmaceutical AG Company Profile and Recent Development

      • 13.3.2 Market Performance

      • 13.3.3 Product and Service Introduction

    • 13.4 Autolus Therapeutics Plc

      • 13.4.1 Autolus Therapeutics Plc Company Profile and Recent Development

      • 13.4.2 Market Performance

      • 13.4.3 Product and Service Introduction

    • 13.5 Takara Bio Inc

      • 13.5.1 Takara Bio Inc Company Profile and Recent Development

      • 13.5.2 Market Performance

      • 13.5.3 Product and Service Introduction

    • 13.6 Celgene Corp

      • 13.6.1 Celgene Corp Company Profile and Recent Development

      • 13.6.2 Market Performance

      • 13.6.3 Product and Service Introduction

    • 13.7 Gilead Sciences Inc

      • 13.7.1 Gilead Sciences Inc Company Profile and Recent Development

      • 13.7.2 Market Performance

      • 13.7.3 Product and Service Introduction

    • 13.8 Amgen Inc

      • 13.8.1 Amgen Inc Company Profile and Recent Development

      • 13.8.2 Market Performance

      • 13.8.3 Product and Service Introduction

    • 13.9 Nkarta Inc

      • 13.9.1 Nkarta Inc Company Profile and Recent Development

      • 13.9.2 Market Performance

      • 13.9.3 Product and Service Introduction

    • 13.10 Cell Medica Ltd

      • 13.10.1 Cell Medica Ltd Company Profile and Recent Development

      • 13.10.2 Market Performance

      • 13.10.3 Product and Service Introduction

    • 13.11 Beijing Immunochina Medical Science & Technology Co Ltd

      • 13.11.1 Beijing Immunochina Medical Science & Technology Co Ltd Company Profile and Recent Development

      • 13.11.2 Market Performance

      • 13.11.3 Product and Service Introduction

    • 13.12 Hebei Senlang Biotechnology Inc Ltd

      • 13.12.1 Hebei Senlang Biotechnology Inc Ltd Company Profile and Recent Development

      • 13.12.2 Market Performance

      • 13.12.3 Product and Service Introduction

    • 13.13 Kite Pharma Inc

      • 13.13.1 Kite Pharma Inc Company Profile and Recent Development

      • 13.13.2 Market Performance

      • 13.13.3 Product and Service Introduction

    • 13.14 Bristol-Myers Squibb Co

      • 13.14.1 Bristol-Myers Squibb Co Company Profile and Recent Development

      • 13.14.2 Market Performance

      • 13.14.3 Product and Service Introduction

    • 13.15 Nanjing Legend Biotech Co Ltd

      • 13.15.1 Nanjing Legend Biotech Co Ltd Company Profile and Recent Development

      • 13.15.2 Market Performance

      • 13.15.3 Product and Service Introduction

    • 13.16 Novartis AG

      • 13.16.1 Novartis AG Company Profile and Recent Development

      • 13.16.2 Market Performance

      • 13.16.3 Product and Service Introduction

    • 13.17 Juno Therapeutics Inc

      • 13.17.1 Juno Therapeutics Inc Company Profile and Recent Development

      • 13.17.2 Market Performance

      • 13.17.3 Product and Service Introduction

    • 13.18 Guangzhou Anjie Biomedical Technology Co Ltd

      • 13.18.1 Guangzhou Anjie Biomedical Technology Co Ltd Company Profile and Recent Development

      • 13.18.2 Market Performance

      • 13.18.3 Product and Service Introduction

    • 13.19 NantKwest Inc

      • 13.19.1 NantKwest Inc Company Profile and Recent Development

      • 13.19.2 Market Performance

      • 13.19.3 Product and Service Introduction

    • 13.20 bluebird bio Inc

      • 13.20.1 bluebird bio Inc Company Profile and Recent Development

      • 13.20.2 Market Performance

      • 13.20.3 Product and Service Introduction

    • 13.21 HRAIN Biotechnology Co Ltd

      • 13.21.1 HRAIN Biotechnology Co Ltd Company Profile and Recent Development

      • 13.21.2 Market Performance

      • 13.21.3 Product and Service Introduction

    • 13.22 Bellicum Pharmaceuticals Inc

      • 13.22.1 Bellicum Pharmaceuticals Inc Company Profile and Recent Development

      • 13.22.2 Market Performance

      • 13.22.3 Product and Service Introduction

    • 13.23 Ono Pharmaceutical Co Ltd

      • 13.23.1 Ono Pharmaceutical Co Ltd Company Profile and Recent Development

      • 13.23.2 Market Performance

      • 13.23.3 Product and Service Introduction

    • 13.24 Daiichi Sankyo Co Ltd

      • 13.24.1 Daiichi Sankyo Co Ltd Company Profile and Recent Development

      • 13.24.2 Market Performance

      • 13.24.3 Product and Service Introduction

    • 13.25 Sorrento Therapeutics Inc

      • 13.25.1 Sorrento Therapeutics Inc Company Profile and Recent Development

      • 13.25.2 Market Performance

      • 13.25.3 Product and Service Introduction

    • 13.26 Celularity Inc

      • 13.26.1 Celularity Inc Company Profile and Recent Development

      • 13.26.2 Market Performance

      • 13.26.3 Product and Service Introduction

    • 13.27 Hangzhou Converd Co Ltd

      • 13.27.1 Hangzhou Converd Co Ltd Company Profile and Recent Development

      • 13.27.2 Market Performance

      • 13.27.3 Product and Service Introduction

    • 13.28 Cellular Biomedicine Group Inc

      • 13.28.1 Cellular Biomedicine Group Inc Company Profile and Recent Development

      • 13.28.2 Market Performance

      • 13.28.3 Product and Service Introduction

    • 13.29 CARsgen Therapeutics Ltd

      • 13.29.1 CARsgen Therapeutics Ltd Company Profile and Recent Development

      • 13.29.2 Market Performance

      • 13.29.3 Product and Service Introduction

    The List of Tables and Figures

    • Figure Product Picture

    • Figure China Adoptive Cellular Immunotherapy Market Size and Growth Rate of TIL from 2016 to 2027

    • Figure China Adoptive Cellular Immunotherapy Market Size and Growth Rate of LAK from 2016 to 2027

    • Figure China Adoptive Cellular Immunotherapy Market Size and Growth Rate of CAR-T from 2016 to 2027

    • Figure China Adoptive Cellular Immunotherapy Market Size and Growth Rate of TCR-T from 2016 to 2027

    • Figure China Adoptive Cellular Immunotherapy Market Size and Growth Rate of CIK from 2016 to 2027

    • Figure China Adoptive Cellular Immunotherapy Market Size and Growth Rate of NK from 2016 to 2027

    • Figure China Adoptive Cellular Immunotherapy Market Size and Growth Rate of DC from 2016 to 2027

    • Figure China Adoptive Cellular Immunotherapy Market Size and Growth Rate of Other from 2016 to 2027

    • Figure Market Share by Type in 2016

    • Figure Market Share by Type in 2021

    • Figure Market Share by Type in 2027

    • Figure China Adoptive Cellular Immunotherapy Market Size and Growth Rate of Hospital from 2016 to 2027

    • Figure China Adoptive Cellular Immunotherapy Market Size and Growth Rate of Cancer Hospital from 2016 to 2027

    • Figure China Adoptive Cellular Immunotherapy Market Size and Growth Rate of Centers for Disease Control and Prevention from 2016 to 2027

    • Figure China Adoptive Cellular Immunotherapy Market Size and Growth Rate of Rehabilitation Center from 2016 to 2027

    • Figure China Adoptive Cellular Immunotherapy Market Size and Growth Rate of Other from 2016 to 2027

    • Figure Market Share by End-User in 2016

    • Figure Market Share by End-User in 2021

    • Figure Market Share by End-User in 2027

    • Figure North China Adoptive Cellular Immunotherapy Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Central China Adoptive Cellular Immunotherapy Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure South China Adoptive Cellular Immunotherapy Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure East China Adoptive Cellular Immunotherapy Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northeast China Adoptive Cellular Immunotherapy Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Southwest China Adoptive Cellular Immunotherapy Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northwest China Adoptive Cellular Immunotherapy Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Development Trends and Industry Dynamics of Adoptive Cellular Immunotherapy Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2020

    • Figure Market Share of TOP 5 Players in 2021

    • Figure Market Share of TOP 6 Players from 2016 to 2021

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Figure Coronavirus (COVID-19) Map of China

    • Table Coronavirus (COVID-19) Impact on the Industry

    • Figure Specifications of Different Types of Adoptive Cellular Immunotherapy

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Adoptive Cellular Immunotherapy by Different Types from 2016 to 2027

    • Table Consumption Share of Adoptive Cellular Immunotherapy by Different Types from 2016 to 2027

    • Figure Market Size and Growth Rate of TIL

    • Figure Market Size and Growth Rate of LAK

    • Figure Market Size and Growth Rate of CAR-T

    • Figure Market Size and Growth Rate of TCR-T

    • Figure Market Size and Growth Rate of CIK

    • Figure Market Size and Growth Rate of NK

    • Figure Market Size and Growth Rate of DC

    • Figure Market Size and Growth Rate of Other

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Figure Consumption of Adoptive Cellular Immunotherapy by Different End-Users from 2016 to 2027

    • Table Consumption Share of Adoptive Cellular Immunotherapy by Different End-Users from 2016 to 2027

    • Figure Market Size and Growth Rate of Hospital

    • Figure Market Size and Growth Rate of Cancer Hospital

    • Figure Market Size and Growth Rate of Centers for Disease Control and Prevention

    • Figure Market Size and Growth Rate of Rehabilitation Center

    • Figure Market Size and Growth Rate of Other

    • Table China Adoptive Cellular Immunotherapy Production by Regions

    • Table China Adoptive Cellular Immunotherapy Production Share by Regions

    • Figure China Adoptive Cellular Immunotherapy Production Share by Regions in 2016

    • Figure China Adoptive Cellular Immunotherapy Production Share by Regions in 2021

    • Figure China Adoptive Cellular Immunotherapy Production Share by Regions in 2027

    • Table China Adoptive Cellular Immunotherapy Consumption by Regions

    • Table China Adoptive Cellular Immunotherapy Consumption Share by Regions

    • Figure China Adoptive Cellular Immunotherapy Consumption Share by Regions in 2016

    • Figure China Adoptive Cellular Immunotherapy Consumption Share by Regions in 2021

    • Figure China Adoptive Cellular Immunotherapy Consumption Share by Regions in 2027

    • Table North China Adoptive Cellular Immunotherapy Consumption by Types from 2016 to 2027

    • Table North China Adoptive Cellular Immunotherapy Consumption Share by Types from 2016 to 2027

    • Figure North China Adoptive Cellular Immunotherapy Consumption Share by Types in 2016

    • Figure North China Adoptive Cellular Immunotherapy Consumption Share by Types in 2021

    • Figure North China Adoptive Cellular Immunotherapy Consumption Share by Types in 2027

    • Table North China Adoptive Cellular Immunotherapy Consumption by End-Users from 2016 to 2027

    • Table North China Adoptive Cellular Immunotherapy Consumption Share by End-Users from 2016 to 2027

    • Figure North China Adoptive Cellular Immunotherapy Consumption Share by End-Users in 2016

    • Figure North China Adoptive Cellular Immunotherapy Consumption Share by End-Users in 2021

    • Figure North China Adoptive Cellular Immunotherapy Consumption Share by End-Users in 2027

    • Table Central China Adoptive Cellular Immunotherapy Consumption by Types from 2016 to 2027

    • Table Central China Adoptive Cellular Immunotherapy Consumption Share by Types from 2016 to 2027

    • Figure Central China Adoptive Cellular Immunotherapy Consumption Share by Types in 2016

    • Figure Central China Adoptive Cellular Immunotherapy Consumption Share by Types in 2021

    • Figure Central China Adoptive Cellular Immunotherapy Consumption Share by Types in 2027

    • Table Central China Adoptive Cellular Immunotherapy Consumption by End-Users from 2016 to 2027

    • Table Central China Adoptive Cellular Immunotherapy Consumption Share by End-Users from 2016 to 2027

    • Figure Central China Adoptive Cellular Immunotherapy Consumption Share by End-Users in 2016

    • Figure Central China Adoptive Cellular Immunotherapy Consumption Share by End-Users in 2021

    • Figure Central China Adoptive Cellular Immunotherapy Consumption Share by End-Users in 2027

    • Table South China Adoptive Cellular Immunotherapy Consumption by Types from 2016 to 2027

    • Table South China Adoptive Cellular Immunotherapy Consumption Share by Types from 2016 to 2027

    • Figure South China Adoptive Cellular Immunotherapy Consumption Share by Types in 2016

    • Figure South China Adoptive Cellular Immunotherapy Consumption Share by Types in 2021

    • Figure South China Adoptive Cellular Immunotherapy Consumption Share by Types in 2027

    • Table South China Adoptive Cellular Immunotherapy Consumption by End-Users from 2016 to 2027

    • Table South China Adoptive Cellular Immunotherapy Consumption Share by End-Users from 2016 to 2027

    • Figure South China Adoptive Cellular Immunotherapy Consumption Share by End-Users in 2016

    • Figure South China Adoptive Cellular Immunotherapy Consumption Share by End-Users in 2021

    • Figure South China Adoptive Cellular Immunotherapy Consumption Share by End-Users in 2027

    • Table East China Adoptive Cellular Immunotherapy Consumption by Types from 2016 to 2027

    • Table East China Adoptive Cellular Immunotherapy Consumption Share by Types from 2016 to 2027

    • Figure East China Adoptive Cellular Immunotherapy Consumption Share by Types in 2016

    • Figure East China Adoptive Cellular Immunotherapy Consumption Share by Types in 2021

    • Figure East China Adoptive Cellular Immunotherapy Consumption Share by Types in 2027

    • Table East China Adoptive Cellular Immunotherapy Consumption by End-Users from 2016 to 2027

    • Table East China Adoptive Cellular Immunotherapy Consumption Share by End-Users from 2016 to 2027

    • Figure East China Adoptive Cellular Immunotherapy Consumption Share by End-Users in 2016

    • Figure East China Adoptive Cellular Immunotherapy Consumption Share by End-Users in 2021

    • Figure East China Adoptive Cellular Immunotherapy Consumption Share by End-Users in 2027

    • Table Northeast China Adoptive Cellular Immunotherapy Consumption by Types from 2016 to 2027

    • Table Northeast China Adoptive Cellular Immunotherapy Consumption Share by Types from 2016 to 2027

    • Figure Northeast China Adoptive Cellular Immunotherapy Consumption Share by Types in 2016

    • Figure Northeast China Adoptive Cellular Immunotherapy Consumption Share by Types in 2021

    • Figure Northeast China Adoptive Cellular Immunotherapy Consumption Share by Types in 2027

    • Table Northeast China Adoptive Cellular Immunotherapy Consumption by End-Users from 2016 to 2027

    • Table Northeast China Adoptive Cellular Immunotherapy Consumption Share by End-Users from 2016 to 2027

    • Figure Northeast China Adoptive Cellular Immunotherapy Consumption Share by End-Users in 2016

    • Figure Northeast China Adoptive Cellular Immunotherapy Consumption Share by End-Users in 2021

    • Figure Northeast China Adoptive Cellular Immunotherapy Consumption Share by End-Users in 2027

    • Table Southwest China Adoptive Cellular Immunotherapy Consumption by Types from 2016 to 2027

    • Table Southwest China Adoptive Cellular Immunotherapy Consumption Share by Types from 2016 to 2027

    • Figure Southwest China Adoptive Cellular Immunotherapy Consumption Share by Types in 2016

    • Figure Southwest China Adoptive Cellular Immunotherapy Consumption Share by Types in 2021

    • Figure Southwest China Adoptive Cellular Immunotherapy Consumption Share by Types in 2027

    • Table Southwest China Adoptive Cellular Immunotherapy Consumption by End-Users from 2016 to 2027

    • Table Southwest China Adoptive Cellular Immunotherapy Consumption Share by End-Users from 2016 to 2027

    • Figure Southwest China Adoptive Cellular Immunotherapy Consumption Share by End-Users in 2016

    • Figure Southwest China Adoptive Cellular Immunotherapy Consumption Share by End-Users in 2021

    • Figure Southwest China Adoptive Cellular Immunotherapy Consumption Share by End-Users in 2027

    • Table Northwest China Adoptive Cellular Immunotherapy Consumption by Types from 2016 to 2027

    • Table Northwest China Adoptive Cellular Immunotherapy Consumption Share by Types from 2016 to 2027

    • Figure Northwest China Adoptive Cellular Immunotherapy Consumption Share by Types in 2016

    • Figure Northwest China Adoptive Cellular Immunotherapy Consumption Share by Types in 2021

    • Figure Northwest China Adoptive Cellular Immunotherapy Consumption Share by Types in 2027

    • Table Northwest China Adoptive Cellular Immunotherapy Consumption by End-Users from 2016 to 2027

    • Table Northwest China Adoptive Cellular Immunotherapy Consumption Share by End-Users from 2016 to 2027

    • Figure Northwest China Adoptive Cellular Immunotherapy Consumption Share by End-Users in 2016

    • Figure Northwest China Adoptive Cellular Immunotherapy Consumption Share by End-Users in 2021

    • Figure Northwest China Adoptive Cellular Immunotherapy Consumption Share by End-Users in 2027

    • Table Company Profile and Development Status of Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd

    • Figure Sales and Growth Rate Analysis of Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd

    • Figure Revenue and Market Share Analysis of Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd

    • Table Product and Service Introduction of Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd

    • Table Company Profile and Development Status of Celyad SA

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Celyad SA

    • Figure Sales and Growth Rate Analysis of Celyad SA

    • Figure Revenue and Market Share Analysis of Celyad SA

    • Table Product and Service Introduction of Celyad SA

    • Table Company Profile and Development Status of Fosun Pharmaceutical AG

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Fosun Pharmaceutical AG

    • Figure Sales and Growth Rate Analysis of Fosun Pharmaceutical AG

    • Figure Revenue and Market Share Analysis of Fosun Pharmaceutical AG

    • Table Product and Service Introduction of Fosun Pharmaceutical AG

    • Table Company Profile and Development Status of Autolus Therapeutics Plc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Autolus Therapeutics Plc

    • Figure Sales and Growth Rate Analysis of Autolus Therapeutics Plc

    • Figure Revenue and Market Share Analysis of Autolus Therapeutics Plc

    • Table Product and Service Introduction of Autolus Therapeutics Plc

    • Table Company Profile and Development Status of Takara Bio Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Takara Bio Inc

    • Figure Sales and Growth Rate Analysis of Takara Bio Inc

    • Figure Revenue and Market Share Analysis of Takara Bio Inc

    • Table Product and Service Introduction of Takara Bio Inc

    • Table Company Profile and Development Status of Celgene Corp

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Celgene Corp

    • Figure Sales and Growth Rate Analysis of Celgene Corp

    • Figure Revenue and Market Share Analysis of Celgene Corp

    • Table Product and Service Introduction of Celgene Corp

    • Table Company Profile and Development Status of Gilead Sciences Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Gilead Sciences Inc

    • Figure Sales and Growth Rate Analysis of Gilead Sciences Inc

    • Figure Revenue and Market Share Analysis of Gilead Sciences Inc

    • Table Product and Service Introduction of Gilead Sciences Inc

    • Table Company Profile and Development Status of Amgen Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Amgen Inc

    • Figure Sales and Growth Rate Analysis of Amgen Inc

    • Figure Revenue and Market Share Analysis of Amgen Inc

    • Table Product and Service Introduction of Amgen Inc

    • Table Company Profile and Development Status of Nkarta Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Nkarta Inc

    • Figure Sales and Growth Rate Analysis of Nkarta Inc

    • Figure Revenue and Market Share Analysis of Nkarta Inc

    • Table Product and Service Introduction of Nkarta Inc

    • Table Company Profile and Development Status of Cell Medica Ltd

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Cell Medica Ltd

    • Figure Sales and Growth Rate Analysis of Cell Medica Ltd

    • Figure Revenue and Market Share Analysis of Cell Medica Ltd

    • Table Product and Service Introduction of Cell Medica Ltd

    • Table Company Profile and Development Status of Beijing Immunochina Medical Science & Technology Co Ltd

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Beijing Immunochina Medical Science & Technology Co Ltd

    • Figure Sales and Growth Rate Analysis of Beijing Immunochina Medical Science & Technology Co Ltd

    • Figure Revenue and Market Share Analysis of Beijing Immunochina Medical Science & Technology Co Ltd

    • Table Product and Service Introduction of Beijing Immunochina Medical Science & Technology Co Ltd

    • Table Company Profile and Development Status of Hebei Senlang Biotechnology Inc Ltd

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Hebei Senlang Biotechnology Inc Ltd

    • Figure Sales and Growth Rate Analysis of Hebei Senlang Biotechnology Inc Ltd

    • Figure Revenue and Market Share Analysis of Hebei Senlang Biotechnology Inc Ltd

    • Table Product and Service Introduction of Hebei Senlang Biotechnology Inc Ltd

    • Table Company Profile and Development Status of Kite Pharma Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Kite Pharma Inc

    • Figure Sales and Growth Rate Analysis of Kite Pharma Inc

    • Figure Revenue and Market Share Analysis of Kite Pharma Inc

    • Table Product and Service Introduction of Kite Pharma Inc

    • Table Company Profile and Development Status of Bristol-Myers Squibb Co

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bristol-Myers Squibb Co

    • Figure Sales and Growth Rate Analysis of Bristol-Myers Squibb Co

    • Figure Revenue and Market Share Analysis of Bristol-Myers Squibb Co

    • Table Product and Service Introduction of Bristol-Myers Squibb Co

    • Table Company Profile and Development Status of Nanjing Legend Biotech Co Ltd

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Nanjing Legend Biotech Co Ltd

    • Figure Sales and Growth Rate Analysis of Nanjing Legend Biotech Co Ltd

    • Figure Revenue and Market Share Analysis of Nanjing Legend Biotech Co Ltd

    • Table Product and Service Introduction of Nanjing Legend Biotech Co Ltd

    • Table Company Profile and Development Status of Novartis AG

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis AG

    • Figure Sales and Growth Rate Analysis of Novartis AG

    • Figure Revenue and Market Share Analysis of Novartis AG

    • Table Product and Service Introduction of Novartis AG

    • Table Company Profile and Development Status of Juno Therapeutics Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Juno Therapeutics Inc

    • Figure Sales and Growth Rate Analysis of Juno Therapeutics Inc

    • Figure Revenue and Market Share Analysis of Juno Therapeutics Inc

    • Table Product and Service Introduction of Juno Therapeutics Inc

    • Table Company Profile and Development Status of Guangzhou Anjie Biomedical Technology Co Ltd

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Guangzhou Anjie Biomedical Technology Co Ltd

    • Figure Sales and Growth Rate Analysis of Guangzhou Anjie Biomedical Technology Co Ltd

    • Figure Revenue and Market Share Analysis of Guangzhou Anjie Biomedical Technology Co Ltd

    • Table Product and Service Introduction of Guangzhou Anjie Biomedical Technology Co Ltd

    • Table Company Profile and Development Status of NantKwest Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of NantKwest Inc

    • Figure Sales and Growth Rate Analysis of NantKwest Inc

    • Figure Revenue and Market Share Analysis of NantKwest Inc

    • Table Product and Service Introduction of NantKwest Inc

    • Table Company Profile and Development Status of bluebird bio Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of bluebird bio Inc

    • Figure Sales and Growth Rate Analysis of bluebird bio Inc

    • Figure Revenue and Market Share Analysis of bluebird bio Inc

    • Table Product and Service Introduction of bluebird bio Inc

    • Table Company Profile and Development Status of HRAIN Biotechnology Co Ltd

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of HRAIN Biotechnology Co Ltd

    • Figure Sales and Growth Rate Analysis of HRAIN Biotechnology Co Ltd

    • Figure Revenue and Market Share Analysis of HRAIN Biotechnology Co Ltd

    • Table Product and Service Introduction of HRAIN Biotechnology Co Ltd

    • Table Company Profile and Development Status of Bellicum Pharmaceuticals Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bellicum Pharmaceuticals Inc

    • Figure Sales and Growth Rate Analysis of Bellicum Pharmaceuticals Inc

    • Figure Revenue and Market Share Analysis of Bellicum Pharmaceuticals Inc

    • Table Product and Service Introduction of Bellicum Pharmaceuticals Inc

    • Table Company Profile and Development Status of Ono Pharmaceutical Co Ltd

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Ono Pharmaceutical Co Ltd

    • Figure Sales and Growth Rate Analysis of Ono Pharmaceutical Co Ltd

    • Figure Revenue and Market Share Analysis of Ono Pharmaceutical Co Ltd

    • Table Product and Service Introduction of Ono Pharmaceutical Co Ltd

    • Table Company Profile and Development Status of Daiichi Sankyo Co Ltd

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Daiichi Sankyo Co Ltd

    • Figure Sales and Growth Rate Analysis of Daiichi Sankyo Co Ltd

    • Figure Revenue and Market Share Analysis of Daiichi Sankyo Co Ltd

    • Table Product and Service Introduction of Daiichi Sankyo Co Ltd

    • Table Company Profile and Development Status of Sorrento Therapeutics Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sorrento Therapeutics Inc

    • Figure Sales and Growth Rate Analysis of Sorrento Therapeutics Inc

    • Figure Revenue and Market Share Analysis of Sorrento Therapeutics Inc

    • Table Product and Service Introduction of Sorrento Therapeutics Inc

    • Table Company Profile and Development Status of Celularity Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Celularity Inc

    • Figure Sales and Growth Rate Analysis of Celularity Inc

    • Figure Revenue and Market Share Analysis of Celularity Inc

    • Table Product and Service Introduction of Celularity Inc

    • Table Company Profile and Development Status of Hangzhou Converd Co Ltd

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Hangzhou Converd Co Ltd

    • Figure Sales and Growth Rate Analysis of Hangzhou Converd Co Ltd

    • Figure Revenue and Market Share Analysis of Hangzhou Converd Co Ltd

    • Table Product and Service Introduction of Hangzhou Converd Co Ltd

    • Table Company Profile and Development Status of Cellular Biomedicine Group Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Cellular Biomedicine Group Inc

    • Figure Sales and Growth Rate Analysis of Cellular Biomedicine Group Inc

    • Figure Revenue and Market Share Analysis of Cellular Biomedicine Group Inc

    • Table Product and Service Introduction of Cellular Biomedicine Group Inc

    • Table Company Profile and Development Status of CARsgen Therapeutics Ltd

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of CARsgen Therapeutics Ltd

    • Figure Sales and Growth Rate Analysis of CARsgen Therapeutics Ltd

    • Figure Revenue and Market Share Analysis of CARsgen Therapeutics Ltd

    • Table Product and Service Introduction of CARsgen Therapeutics Ltd


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US